Today

Agents

Chat

Arena

Discover

More

App

Oruka Therapeutics CEO Lawrence Klein sells USD 6.85 million in common shares - ORKA News | Rallies

Oruka Therapeutics CEO Lawrence Klein sells USD 6.85 million in common shares

ORKA•2026-09-01

CEO shares sale and warrant exercise

Oruka Therapeutics CEO Lawrence Otto Klein sold 74,999 shares on Sep. 1, 2026 at about $91.81.
He also acquired 75,000 shares at $7.8 through an employee warrant exercise.
Directly held common stock fell to 925,580 shares following the transactions.
Employee warrant holdings rose to 1,553,513 shares.

Related News

Crexendo CTO David Tzat-kin Wang sells 25,000 common shares worth $162,500

CXDO•2026-09-01

Pennant Group to join Jefferies Healthcare Services Conference fireside chat

PNTG•2026-09-01

Venezuela's oil exports almost unchanged at 1.17 million bpd in Aug, data says

Sources

S

Oruka Therapeutics CEO Lawrence Klein sells USD 6.85 million in common shares

Sec

•

2026-09-01

nLIGHT director William Gossman sells 15,000 shares worth $665,400

LASR•2026-09-01

Peoples Bancorp of North Carolina director Robert C. Abernethy Jr disposes of 1,200 common shares worth $51,756

PEBK•2026-09-01